Celecoxib inhibits osteoblast maturation by suppressing the expression of Wnt target genes
Non-steroidal anti-inflammatory drugs (NSAIDs) have been shown to impair bone healing. We previously reported that in colon cancer cells, celecoxib, a COX-2-selective NSAID, inhibited the canonical Wnt/β-catenin signaling pathway. Since this pathway also plays an important role in osteoblast growth...
Main Authors: | Akihiro Nagano, Masaki Arioka, Fumi Takahashi-Yanaga, Etsuko Matsuzaki, Toshiyuki Sasaguri |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-01-01
|
Series: | Journal of Pharmacological Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861316301591 |
Similar Items
-
Regulation of Osteoblast Metabolism by Wnt Signaling
by: Megan C. Moorer, et al.
Published: (2018-08-01) -
Effects of WNT1 c.110 T>C and c.505G>T mutations on osteoblast differentiation via the WNT1/β-catenin signaling pathway
by: Bashan Zhang, et al.
Published: (2021-06-01) -
Roles of Wnt signaling in bone formation and resorption
by: Yasuhiro Kobayashi, et al.
Published: (2008-07-01) -
Spatiotemporal Analysis of Osteoblast Morphology and Wnt Signal‐Induced Osteoblast Reactivation during Bone Modeling in Vitro
by: Naoki Tsuji, et al.
Published: (2022-11-01) -
Mechanism of inhibition of growth and metastasis of colon cancer by celecoxib analog OSU-03013 via wnt signaling pathway
by: ChunYong Yang, et al.
Published: (2024-02-01)